1. A pharmaceutical composition for treating or preventing liver cancer, comprising a combination of a chemotherapeutic agent and an anti-glypican 3 antibody. ! 2. The pharmaceutical composition according to claim 1, where this pharmaceutical composition is a combined preparation. ! 3. The pharmaceutical composition according to claim 1, where this chemotherapeutic agent and this anti-glypican 3-antibody are administered together. ! 4. The pharmaceutical composition according to claim 3, where this chemotherapeutic agent and this anti-glypican 3 antibody are administered simultaneously or sequentially. ! 5. The pharmaceutical composition according to claim 3, where this chemotherapeutic agent and this anti-glypican 3 antibody are administered separately. ! 6. A pharmaceutical composition for treating or preventing liver cancer for use in combination with a chemotherapeutic agent, said composition comprising an anti-glypican 3 antibody as an active ingredient. ! 7. The pharmaceutical composition according to claim 6, where this anti-glypican 3-antibody is administered simultaneously with a chemotherapeutic agent. ! 8. The pharmaceutical composition of claim 6, wherein the anti-glypican 3 antibody is administered before or after a chemotherapeutic agent. ! 9. A pharmaceutical composition for treating or preventing liver cancer for use in combination with an anti-glypican 3 antibody, said composition comprising a chemotherapeutic agent as an active ingredient. ! 10. The pharmaceutical composition according to claim 9, where this chemotherapeutic agent is administered simultaneously with anti-glypican 3 antibody. ! 11. The pharmaceutical composition according to claim 9, where this chemotherapeutic agent is administered before or after administration of anti-glypican 3 antibodies. !121. Фармацевтическая композиция для лечения или предупреждения рака печени, содержащая комбинацию химиотерапевтического агента и анти-глипикан 3-антитела. ! 2. Фармацевтическая композиция п
